Introduction
============

Endophthalmitis has become a rare surgical complication. However, it remains the most important concern for surgeons, because it can have devastating consequences on vision. Bacteria exist in the anterior chamber of the eye in 8%--22% of patients by the end of surgery.[@b1-opth-8-2013],[@b2-opth-8-2013] Investigation of the bacteria that cause endophthalmitis after cataract surgery has revealed that bacterial flora from the patient's conjunctiva and eyelid are the primary sources of infection.[@b3-opth-8-2013] Therefore, it is generally believed that a preoperative decrease in bacterial contamination in the conjunctival sac may decrease the risk of postoperative endophthalmitis.

According to Ciulla et al[@b4-opth-8-2013] only preoperative povidone--iodine (PI) has received clinical recommendations. However, there is limited evidence on the efficacy of prophylactic antibiotic administration, including preoperative topical antibiotics, subconjunctival antibiotic injections, and antibiotic irrigation.

Typically, 5% or 10% PI has been used worldwide to disinfect the periocular area and surgical field before surgery. Although preoperative topical antibiotics can decrease the bacteria in the conjunctival flora, a complete elimination of bacteria is unlikely. However, PI is advantageous because of its low cost, broad-spectrum activity, rapid bactericidal rate, and the lack of resistance to its bactericidal effects.[@b5-opth-8-2013] PI and preoperative topical antibiotics are effective and well-tolerated. However, 20%--40% of surgical field cultures are positive, even after PI and antibiotic application.[@b6-opth-8-2013]--[@b8-opth-8-2013] Despite the use of sterile draping, bacteria from the eyelashes or eyelids may contaminate the conjunctival surface during surgery. To address these problems, Shimada et al[@b9-opth-8-2013] reported that intraoperative irrigation of the surgical field with PI resulted in extremely low contamination rates in the anterior chamber at the end of surgery.

The Endophthalmitis Surgery Group and the European Society of Cataract and Refractive Surgeons conducted a multicenter clinical trial that identified a five-fold decrease in infection rates with the postoperative intracameral administration of cefuroxime.[@b10-opth-8-2013] According to a 6-year Swedish national study, intracameral cefuroxime was responsible for a nationwide decrease in the incidence of postoperative endophthalmitis.[@b11-opth-8-2013] Other reports have documented the effectiveness and safety of intracameral moxifloxacin.[@b12-opth-8-2013]--[@b15-opth-8-2013]

Although there is an abundance of information on prophylaxis, there is little definitive evidence proving a decrease in the postoperative endophthalmitis rate. Therefore, many surgeons have been ambivalent toward prophylactic strategies for postoperative endophthalmitis. In a previous study from 2012, we surveyed ophthalmic surgeons from six regions in Japan and evaluated their use of prophylactic antibiotics for patients undergoing cataract surgery. In the current study, we evaluated the use of perioperative iodine compounds and prophylactic antibiotics, by surveying surgeons from eight regions in Japan, to clarify the national trends of disinfection and antibiotic choice.

Materials and methods
=====================

The survey included a questionnaire that was administered either by mail or through personal interviews from February 1 to March 1, 2014. We selected the following eight regions to avoid an uneven sampling distribution: Fukushima, Ishikawa, Saitama, Wakayama, San'in, Fukuoka, Shiga, and Kagawa ([Figure 1](#f1-opth-8-2013){ref-type="fig"}). In 2012, we conducted a similar survey[@b16-opth-8-2013] in six of the eight regions, not including Shiga and Kagawa. For comparison, the participants in Shiga and Kagawa were requested to fulfill the surveys from both 2012 and 2014. The surgeons involved in this study were selected using an official ophthalmologist list. As a result, our survey targeted a broad range of ophthalmologists, regardless of their academic orientation. This may better reflect the awareness of ophthalmologists in general, including cataract specialists and cataract surgeons.

Results
=======

A total of 572 surgeons were contacted, of whom 386 (67%) responded. Our survey consisted of both low- and high-volume surgeons ([Table 1](#t1-opth-8-2013){ref-type="table"}). According to unofficial figures, there are an estimated 5,000 cataract surgeons in Japan. Therefore, this survey sampled approximately 8% of all cataract surgeons in Japan.

Polyvinyl alcohol--iodine (PAI) and PI are iodine compounds used in Japan. Before surgery, 94% (PI: 79%; PAI: 15%) and 85% (PI: 36%; PAI: 49%) of surgeons performed periocular skin disinfection and conjunctival irrigation with iodine compounds, respectively ([Table 2](#t2-opth-8-2013){ref-type="table"}). Preoperative conjunctival iodine was primarily used as an eye wash (irrigation: 95%) and less often as eye drops (5%).

Periocular disinfection was performed primarily using 10% or 5% PI. For conjunctival disinfection after periocular disinfection, 2.5%--0.625% diluted PI or diluted PAI, equivalent to 0.5%--0.25% PI, was used ([Table 3](#t3-opth-8-2013){ref-type="table"}). We determined that 31% of surgeons waited for 30 seconds or more between periocular disinfection and conjunctival disinfection.

Among the surgeons who did not use preoperative iodine compounds, 5% and 1% used chlorhexidine gluconate and benzethonium chloride, respectively. Chlorhexidine gluconate, ozonated solution, benzethonium chloride, and balanced salt solution were used for conjunctival irrigation by 9%, 3%, 2%, and 2% of surgeons, respectively.

During surgery, 14% of surgeons used iodine several times, including immediately before intraocular lens insertion, whereas 7% used the Shimada technique (repeated iodine irrigation) ([Table 2](#t2-opth-8-2013){ref-type="table"}). Fifty-six percent of surgeons who did not use iodine compounds during surgery did not acknowledge the necessity of intraoperative disinfection. In addition, 42% and 28% of surgeons reported concerns about toxicity and the lack of information, respectively.

Preoperative antibiotic eye drops were used by 99% (382/386) of surgeons ([Table 4](#t4-opth-8-2013){ref-type="table"}). Preoperative topical antibiotic was mostly initiated 2--5 days before surgery ([Table 5](#t5-opth-8-2013){ref-type="table"}). Of these, 356 used a fluoroquinolone (combined use with cephem: 27 surgeons) and 12 used only cephem ([Table 6](#t6-opth-8-2013){ref-type="table"}). Preoperative antibiotic eye drops were initiated upon arrival or 1 day before surgery (7%; 26 surgeons), 2--5 days before surgery (83%; 317 surgeons), or 1 week before surgery (10%; 37 surgeons) ([Table 5](#t5-opth-8-2013){ref-type="table"}).

Immediately after surgery, 35% (137/386) of surgeons used antibiotic eye drops ([Table 4](#t4-opth-8-2013){ref-type="table"}), mainly a fluoroquinolone. Subconjunctival antibiotic injections were used by 23% (89/386) of surgeons ([Table 4](#t4-opth-8-2013){ref-type="table"}). Of these, 63 used gentamycin, 17 used cephem, and 6 used a fluoroquinolone ([Table 6](#t6-opth-8-2013){ref-type="table"}). Antibiotics were added to the irrigation bottle by 22% (85/386) of surgeons, with 37 using cephem, 35 using imipenem, and 2 using vancomycin ([Tables 4](#t4-opth-8-2013){ref-type="table"} and [6](#t6-opth-8-2013){ref-type="table"}). Ophthalmic antibiotic ointments were used by 79% (304/386) of surgeons, and most of these ointments contained ofloxacin ([Tables 4](#t4-opth-8-2013){ref-type="table"} and [6](#t6-opth-8-2013){ref-type="table"}); 25 surgeons used erythromycin. Some surgeons reported the use of intracameral antibiotics (7%; 28/386); 22 used moxifloxacin, and 6 used levofloxacin ([Tables 4](#t4-opth-8-2013){ref-type="table"} and [6](#t6-opth-8-2013){ref-type="table"}). All surgeons prescribed postoperative eye drops ([Table 4](#t4-opth-8-2013){ref-type="table"}); 10% (39/386) initiated the drops on the day of surgery. Fluoroquinolones were the most commonly used antibiotics. Postoperative eye drops were continued for more than 1 month by 63% (244/386) of surgeons ([Table 7](#t7-opth-8-2013){ref-type="table"}).

Discussion
==========

Most of the surgeons surveyed in the present study used iodine compounds for preoperative periocular and conjunctival disinfection. According to Berkelman et al the time required until bactericidal properties are exhibited by iodine is approximately 15 seconds, for concentrations of 0.1%--1.0% iodine, but this increases to 30--120 seconds for 2.5%--10% iodine.[@b17-opth-8-2013] This indicates that water is essential for the bactericidal properties of iodine. The dilution of PI results in weakening of the iodine linkage to the carrier polymer, polyvinylpyrroliodine, with a concomitant increase in the amount of free iodine solution. The present study found that 10% or 5% iodine was used for skin disinfection in most patients. However, only 31% of surgeons waited for 30 seconds or more before subsequent conjunctival irrigation with diluted iodine.

In the United States, highly concentrated iodine eye drops are generally used for conjunctival disinfection, but in Japan, diluted iodine compounds are generally used for irrigation. Miño de Kasper et al reported that irrigation with 10 mL of iodine before cataract surgery led to lower culture-positive rates, compared with irrigation with two drops of iodine eye drops.[@b7-opth-8-2013]

Considering that all bacteria in the surgical field cannot be eliminated, even with the use of preoperative eye drops and iodine disinfection, the idea of intraoperative iodine compound use seems reasonable and appropriate. However, only a few surgeons used iodine compounds during surgery, particularly with repeated applications. Some surgeons did not use this technique, for fear of corneal damage or because of lack of information ([Table 2](#t2-opth-8-2013){ref-type="table"}).

Currently, there is no consensus among surgeons regarding the methods and theory of perioperative iodine use. In the present study, there were no drastic changes in the trends of perioperative antibiotic use, including intracameral antibiotic use. Considering that postoperative endophthalmitis is mostly caused by infection with bacteria brought into the eye from the surgical field,[@b3-opth-8-2013],[@b9-opth-8-2013] we believe that it is best to administer antibacterial agents soon after surgery or during surgery.

Fluoroquinolones were the most commonly used perioperative (preoperative, postoperative, and completion of surgery) eye drops. Although moxifloxacin, a representative fluoroquinolone, penetrates well into the anterior chamber, its concentration after use as an eye drop (1.8 μg/mL)[@b18-opth-8-2013] and after subconjunctival injection (3.1 μg/mL)[@b19-opth-8-2013] does not exceed the minimum inhibitory concentration required to inhibit a growth of 90% (MIC~90~) for resistant pathogens such as *Pseudomonas aeruginosa* and methicillin-resistant *Staphylococcus aureus* (MRSA) ([Table 8](#t8-opth-8-2013){ref-type="table"}).

The antibiotic concentration in the anterior chamber 1 hour after ophthalmic ointment administration is only 219 ng/mL,[@b20-opth-8-2013] which is less than the MIC~90~ for most pathogens. Therefore, the effects of antibacterial agents administered via commonly-used methods are limited. In contrast, there is no antibiotic resistance to iodine, which appears to be effective against pathogenic bacteria. On the other hand, intracameral antibiotics have the advantage of providing a sufficient antibiotic concentration during surgery, by themselves. Although intracameral antibiotics are gaining in popularity, as indicated by a comparison with 2012 data (1%; [Table 4](#t4-opth-8-2013){ref-type="table"}), they were used by only 7% of surgeons. Ophthalmologists in Japan still face several barriers, including the lack of commercially-available intracameral cefuroxime. Therefore, surgeons in Japan opt for off-label, broad-spectrum fluoroquinolones ([Table 6](#t6-opth-8-2013){ref-type="table"}), instead of cefuroxime, which is popular in Europe.

Fluoroquinolones are suitable choices as an intracameral agent because they are concentration-dependent drugs, as compared against time-dependent cefuroxime, and because the anterior chamber is characterized by rapid drug turnover.

Our study revealed that periocular and conjunctival iodine use at the initiation of surgery was common, whereas intraoperative iodine use, particularly with repeated applications, was used only at a few institutions. Although the early administration of prophylactic antibiotics has been recommended, they are typically initiated the day after surgery. Ointments and eye drops (and subconjunctival injection) are also common, but their penetration into the anterior chamber may be insufficient. Intracameral antibiotic use is increasing, although only a few surgeons are currently using this technique. The choice of antibiotic administration and disinfection has to be at the surgeon's discretion. However, we believe that the use of intracameral antibiotics and intraoperative iodine compounds should be widely recognized.
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###### 

Distribution of respondents by annual cataract volume

  Volume (cases)   Respondents (n)
  ---------------- -----------------
  \<100            75
  100--300         160
  300--500         69
  \>500            82

###### 

Perioperative disinfection method

                                           2014   2012
  ---------------------------------------- ------ ------
  **Preoperative**                                
  Periocular iodine compounds              94%    ND
  Conjunctival iodine compounds            87%    ND
  Ozonated solution                        3%     ND
  **Intraoperative**                              
  Iodine compounds: several times          14%    ND
  Iodine compounds: repeated application   7%     ND

**Abbreviation:** ND, no data.

###### 

Concentration of preoperative iodine compounds

  ----------------------------------------------------------------------------------------------------------------------------
  Periocular skin PI (231)   Eye wash with PI (115)      Eye wash with PAI[\*](#tfn2-opth-8-2013){ref-type="table-fn"} (151)
  -------------------------- --------------------------- ---------------------------------------------------------------------
  10% or 5%: 83% (191)       10% or 5%: 3% (4)           0.25% to 0.5%: 78% (118)

  0.625% to 2.5%: 17% (40)   0.625% to 2.5%: 74% (85)\   \<0.25%: 22% (33)
                             \<0.625%: 23% (26)          
  ----------------------------------------------------------------------------------------------------------------------------

**Note:**

4-fold diluted PAI is equivalent to 0.5% PI.

**Abbreviations:** PI, povidone--iodine; PAI, polyvinyl alchol--iodine.

###### 

Perioperative and postoperative use of antibiotic prophylaxis

                                      2014 (386)   2012 (368)
  ----------------------------------- ------------ ------------
  Preoperative topical antibiotics    99% (382)    99% (365)
  Perioperative topical antibiotics   35% (137)    42% (155)
  Postoperative topical antibiotics   100% (386)   100% (368)
  Irrigation bottle                   22% (85)     20% (72)
  Intracameral injection              7% (28)      1% (4)
  Subconjunctival injection           23% (89)     22% (82)
  Antibiotic ointment                 79% (304)    86% (318)

**Note:** 2012 includes the data from both present study and previous study (n=16).

###### 

Initiation of preoperative topical antibiotics

                                         2014 (380)   2012 (361)
  -------------------------------------- ------------ ------------
  Upon arrival or 1 day before surgery   7% (26)      12% (43)
  2--5 days before surgery               83% (317)    81% (292)
  1 week before surgery                  10% (37)     7% (26)

**Note:** 2012 includes the data from both present study and previous study (n=16).

###### 

Choice of antibiotics

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                            Preoperative topical antibiotics                    Subconjunctival injection   Intracameral injection            Irrigation bottle   Antibiotic ointment
  ------------------------- --------------------------------------------------- --------------------------- --------------------------------- ------------------- ---------------------
  Fluoroquinolone           356                                                 6                           28\                                                   271 (ofloxacin)
                                                                                                            22 moxifloxacin, 6 levofloxacin                       

  Cephem                    12+27[\*](#tfn6-opth-8-2013){ref-type="table-fn"}   17                                                            37                  

  Aminoglycoside            1                                                   63                                                            6                   2

  Imipenem                                                                      1                                                             35                  

  Erythromycin              1                                                                                                                                     25

  Penicillin                                                                    1                                                             3                   

  Others                                                                        1                                                             2 (vancomycin)      

  Used but not identified   12                                                                                                                2                   6

  Total                     382                                                 89                          28                                85                  304
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Note:**

27 surgeons used cephem combined with fluoroquinolone.

###### 

Duration of postoperative topical antibiotic use

             2014 (386)   2012 (368)
  ---------- ------------ ------------
  \<2 wk     6% (25)      5% (18)
  2--4 wk    30% (117)    28% (102)
  1--2 mth   41% (160)    41% (152)
  \>2 mth    22% (84)     26% (96)

**Note:** 2012 includes the data from both present study and previous study (16).

**Abbreviations:** wk, week; mth, month.

###### 

Bacteria which cause endophthalmitis in Japan

  Bacteria (moxifloxacin: MIC~90~: μg/mL)   Onset: 0--29 days (cases)   Onset: after 1 month (cases)
  ----------------------------------------- --------------------------- ------------------------------
  *P. acnes* (0.25)                         0                           13
  *S. epidermidis* (CNS \>4)                28                          4
  *S. aureus* (MRSA \>4)                    18                          0
  *E. faecalis* (0.5)                       22                          0
  *Streptococcus* sp. (0.5)                 6                           1
  *P. aeruginosa* (\>4)                     4                           0
  Others                                    26                          12
  **Total**                                 104                         30

**Notes:** The numbers shown in parenthesis are MIC90 in each bacteria to moxifloxacin. *S. epidermidis* involves some cases of CNS. *S. aureus* contains 16 cases of MRSA. Copyright © 2003. Translated and adapted from Medical-Aoi Publications, Inc. Hara J. Relation between causative organism and inflamation in pseudophakic endophthalmitis following cataract surgery. *Journal of the Eye*. 2003;(20):657--660.[@b21-opth-8-2013]

**Abbreviations:** MIC~90~, minimum inhibitory concentration, 90%; CNS, coagulase negative *Staphylococcus;* MRSA, methicillin-resistant *Staphylococcus aureus*.
